North America Stomach Cancer Treatment Market Size & Outlook, 2028

Revenue, 2020 (US$M)

$710.7

Forecast, 2028 (US$M)

$2,078.7

CAGR, 2021 - 2028

14.4%

Report Coverage

North America

North America stomach cancer treatment market, 2018-2028 (US$M)

Related Markets

Global Stomach Cancer Treatment Industry Outlook

U.S. Stomach Cancer Treatment Market Outlook

Canada Stomach Cancer Treatment Market Outlook

Europe Stomach Cancer Treatment Market Outlook

Germany Stomach Cancer Treatment Market Outlook

France Stomach Cancer Treatment Market Outlook

Italy Stomach Cancer Treatment Market Outlook

Spain Stomach Cancer Treatment Market Outlook

UK Stomach Cancer Treatment Market Outlook

Asia Pacific Stomach Cancer Treatment Market Outlook

Japan Stomach Cancer Treatment Market Outlook

China Stomach Cancer Treatment Market Outlook

India Stomach Cancer Treatment Market Outlook

Australia Stomach Cancer Treatment Market Outlook

South Korea Stomach Cancer Treatment Market Outlook

Latin America Stomach Cancer Treatment Market Outlook

Mexico Stomach Cancer Treatment Market Outlook

Argentina Stomach Cancer Treatment Market Outlook

Brazil Stomach Cancer Treatment Market Outlook

MEA Stomach Cancer Treatment Market Outlook

South Africa Stomach Cancer Treatment Market Outlook

Saudi Arabia Stomach Cancer Treatment Market Outlook

UAE Stomach Cancer Treatment Market Outlook

North America stomach cancer treatment market highlights

The North America stomach cancer treatment market generated a revenue of USD 710.7 million in 2020.
The market is expected to grow at a CAGR of 14.4% from 2021 to 2028.
In terms of segment, targeted therapy was the largest revenue generating treatment type in 2020.
Immunotherapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.
Country-wise, Canada is expected to register the highest CAGR from 2021 to 2028.

North America data book summary

Market revenue in 2020	USD 710.7 million
Market revenue in 2028	USD 2,078.7 million
Growth rate	14.4% (CAGR from 2020 to 2028)
Largest segment	Targeted therapy
Fastest growing segment	Immunotherapy
Historical data covered	2018 - 2019
Base year for estimation	2020
Forecast period covered	2021 - 2028
Quantitative units	Revenue in USD million
Market segmentation	Standard Chemotherapy, Targeted Therapy, Immunotherapy
Key market players worldwide	Novartis AG ADR, Pfizer Inc, Viatris Inc, Roche Holding AG ADR, Eli Lilly and Co, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Co, Celltrion Healthcare, Samsung Bioepis

Other key industry trends

In terms of revenue, North America region accounted for 20.3% of the global stomach cancer treatment market in 2020.
Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2028.
Europe is the fastest growing regional market and is projected to reach USD 1,990.9 million by 2028.

Key Regions: U.S. , UK , Japan , Brazil , UAE

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Stomach Cancer Treatment Market Scope

Stomach cancer treatment market segmentation & scope

Stomach Cancer Treatment Market Companies

Name	Profile	# Employees	HQ	Website

North America stomach cancer treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stomach cancer treatment market will help companies and investors design strategic landscapes.

Targeted therapy was the largest segment with a revenue share of 53.89% in 2020. Horizon Databook has segmented the North America stomach cancer treatment market based on standard chemotherapy, targeted therapy, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2028.

Reasons to subscribe to North America stomach cancer treatment market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America stomach cancer treatment market databook

Our clientele includes a mix of stomach cancer treatment market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America stomach cancer treatment market , including forecasts for subscribers. This continent databook contains high-level insights into North America stomach cancer treatment market from 2018 to 2028, including revenue numbers, major trends, and company profiles.